News

Filter

Current filters:

Invirase

1 to 9 of 76 results

UK’s MHRA advises on rosiglitazone cardiovascular risk, saquinavir contraindications

11-08-2010

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder for health…

Anti-viralsAvandiaDiabetesGlaxoSmithKlineInvirasePharmaceuticalRegulationRoche

Europe's CHMP to review of ARBs for possible cancer risk; starts Invirase assessment

29-06-2010

The European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) announced,…

Anti-viralsBoehringer IngelheimCardio-vascularEuropeInviraseMicardisPharmaceuticalRegulationRoche

Roche's Invirase non-inferior to Kaletra

05-11-2007

Final 48-week results from a head-to-head trial presented today at the 11th European AIDS Conference,…

Abbott LaboratoriesInviraseRocheSaquinavir Mesylate

Invirase lowers HIV levels with better lipid profile

20-11-2006

Swiss drug major Roche says that data from a study of its protease inhibitor Invirase (saquinavir mesylate)…

EmtricitabineEmtricitabine and Tenofovir Disoproxil FumaraEmtrivaInviraseRocheSaquinavir MesylateTenofovir Disoproxil FumarateTruvadaViread

Roche's new Invirase version OKd in EU

06-06-2005

Swiss drug major Roche has obtained European marketing approval for its new 500mg formulation of Invirase…

InviraseRocheSaquinavir Mesylate

1 to 9 of 76 results

COMPANY SPOTLIGHT

Menarini

Back to top